Literature DB >> 20938028

Epidemiology of Parkinson disease in the city of Kolkata, India: a community-based study.

S K Das1, A K Misra, B K Ray, A Hazra, M K Ghosal, A Chaudhuri, T Roy, T K Banerjee, D K Raut.   

Abstract

OBJECTIVE: No well-designed longitudinal study on Parkinson disease (PD) has been conducted in India. Therefore, we planned to determine the prevalence, incidence, and mortality rates of PD in the city of Kolkata, India, on a stratified random sample through a door-to-door survey.
METHOD: This study was undertaken between 2003 to 2007 with a validated questionnaire by a team consisting of 4 trained field workers in 3 stages. Field workers screened the cases, later confirmed by a specialist doctor. In the third stage, a movement disorders specialist undertook home visits and reviewed all surviving cases after 1 year from last screening. Information on death was collected through verbal autopsy. A nested case-control study (1:3) was also undertaken to determine putative risk factors. The rates were age adjusted to the World Standard Population. RESULT: A total population of 100,802 was screened. The age-adjusted prevalence rate (PR) and average annual incidence rate were 52.85/100,000 and 5.71/100,000 per year, respectively. The slum population showed significantly decreased PR with age compared with the nonslum population. The adjusted average annual mortality rate was 2.89/100,000 per year. The relative risk of death was 8.98. The case-control study showed that tobacco chewing protected and hypertension increased PD occurrence.
CONCLUSION: This study documented lower prevalence and incidence of PD as compared with Caucasian and a few Oriental populations. The mortality rates were comparable. The decreased age-specific PR among slum populations and higher relative risk of death need further probing.

Entities:  

Mesh:

Year:  2010        PMID: 20938028      PMCID: PMC3013482          DOI: 10.1212/WNL.0b013e3181f735a7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Mortality in 33 countries from diseases of the nervous system.

Authors:  I D GOLDBERG; L T KURLAND
Journal:  World Neurol       Date:  1962-06

Review 2.  Update on hypertension and Alzheimer's disease.

Authors:  Ingmar Skoog; Deborah Gustafson
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

3.  Molecular pathogenesis of Parkinson's disease: identification of mutations in the Parkin gene in Indian patients.

Authors:  Arindam Biswas; Arnab Gupta; Tufan Naiya; Gautami Das; Rajarshi Neogi; Somnath Datta; Subhas Mukherjee; Shyamal K Das; Kunal Ray; Jharna Ray
Journal:  Parkinsonism Relat Disord       Date:  2006-06-21       Impact factor: 4.891

Review 4.  Worldwide occurrence of Parkinson's disease: an updated review.

Authors:  Z X Zhang; G C Román
Journal:  Neuroepidemiology       Date:  1993       Impact factor: 3.282

5.  Risk factors of Parkinson's disease in Indian patients.

Authors:  M Behari; A K Srivastava; R R Das; R M Pandey
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

6.  Prevalence of Parkinson's disease in Junín, Buenos Aires Province, Argentina.

Authors:  M O Melcon; D W Anderson; R H Vergara; W A Rocca
Journal:  Mov Disord       Date:  1997-03       Impact factor: 10.338

7.  Prevalence of Parkinson's disease in the Parsi community of Bombay, India.

Authors:  N E Bharucha; E P Bharucha; A E Bharucha; A V Bhise; B S Schoenberg
Journal:  Arch Neurol       Date:  1988-12

8.  Epidemiology of Parkinson's disease in Yonago City, Japan: comparison with a study carried out 12 years ago.

Authors:  M Kusumi; K Nakashima; H Harada; H Nakayama; K Takahashi
Journal:  Neuroepidemiology       Date:  1996       Impact factor: 3.282

9.  Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA.

Authors:  Y S Wang; Y M Shi; Z Y Wu; Y X He; B Z Zhang
Journal:  Chin Med J (Engl)       Date:  1991-11       Impact factor: 2.628

10.  The impact of gender and estrogen on striatal dopaminergic neurotoxicity.

Authors:  D B Miller; S F Ali; J P O'Callaghan; S C Laws
Journal:  Ann N Y Acad Sci       Date:  1998-05-30       Impact factor: 5.691

View more
  14 in total

1.  Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai, Tanzania.

Authors:  Catherine Dotchin; Ahmed Jusabani; Richard Walker
Journal:  J Neurol       Date:  2011-03-26       Impact factor: 4.849

2.  Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.

Authors:  D J Vidyadhara; H Yarreiphang; T R Raju; Phalguni Anand Alladi
Journal:  Mol Neurobiol       Date:  2016-10-04       Impact factor: 5.590

3.  Differences in Neuronal Numbers, Morphology, and Developmental Apoptosis in Mice Nigra Provide Experimental Evidence of Ontogenic Origin of Vulnerability to Parkinson's Disease.

Authors:  D J Vidyadhara; Haorei Yarreiphang; Trichur R Raju; Phalguni Anand Alladi
Journal:  Neurotox Res       Date:  2021-11-11       Impact factor: 3.911

4.  'We call it the shaking illness': perceptions and experiences of Parkinson's disease in rural northern Tanzania.

Authors:  Gerry Mshana; Catherine L Dotchin; Richard W Walker
Journal:  BMC Public Health       Date:  2011-04-08       Impact factor: 3.295

5.  Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study.

Authors:  Kandadai Rukmini Mridula; Rupam Borgohain; Shaik Afshan Jabeen; Gaddamanugu Padmaja; Vcs Srinivasarao Bandaru; Praveen Ankathi; Meena A Kanikannan; Mohammed Shujath Ali Khan
Journal:  Iran J Neurol       Date:  2015-04-04

6.  The Effect of Dual Tasking and Deep Brain Stimulation Frequency Parameters on Gait in Advanced Parkinson's Disease.

Authors:  Swetha Tandra; Rukmini M Kandadai; Ravi P Peddisetty; K J Babu; T Surya Prabha; S A Jabeen; A K Meena; Rupam Borgohain
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383

Review 7.  Epidemiology of Parkinson's Disease-East Versus West.

Authors:  Masoom M Abbas; Zheyu Xu; Louis C S Tan
Journal:  Mov Disord Clin Pract       Date:  2017-12-22

Review 8.  Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat.

Authors:  Mark Walterfang; Yin-Hsiu Chien; Jackie Imrie; Derren Rushton; Danielle Schubiger; Marc C Patterson
Journal:  Orphanet J Rare Dis       Date:  2012-10-06       Impact factor: 4.123

9.  Update on deep brain stimulation in Parkinson's disease.

Authors:  Daniel Martinez-Ramirez; Wei Hu; Alberto R Bona; Michael S Okun; Aparna Wagle Shukla
Journal:  Transl Neurodegener       Date:  2015-06-27       Impact factor: 8.014

Review 10.  Cell based therapies in Parkinson's Disease.

Authors:  Madhuri Behari; Kapil Kumar Singhal
Journal:  Ann Neurosci       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.